Precipio (PRPO) Q4 2025 Earnings Transcript

Image source: The Motley Fool.

DATE

Thursday, April 2, 2026 astatine 5 p.m. ET

CALL PARTICIPANTS

• Chief Executive Officer — Ilan Danieli

Need a punctuation from a Motley Fool analyst? Email [email protected]

Full Conference Call Transcript

Ilan Danieli: Good afternoon, and convey you for joining our 2025 4th fourth and year-end shareholder call. I'd similar to convey everyone who submitted questions up of time. We volition bash our champion to code them during the call. But earlier we statesman our fiscal reappraisal and for those of our shareholders that are comparatively caller to Precipio, I'd similar to instrumentality a infinitesimal to bespeak connected the interaction our enactment has connected patients each day. Behind each diagnostic trial we tally is simply a diligent waiting for answers often during 1 of the astir hard moments of their lives.

Our trial helps physicians find the astir due attraction options for their patients battling cancer, and those answers indispensable beryllium provided rapidly and accurately. While today's treatment volition absorption chiefly connected fiscal show and operational progress, it's important to retrieve that these results yet correspond thing that is beyond dollars and cents. It represents our publication to helping patients and their families navigate their conflict against cancer. Now let's crook to a reappraisal of our show successful 2025. 2025 was a twelvemonth of fiscal and strategical inflection. At the opening of past year, we acceptable retired to execute an important nonsubjective for Precipio, modulation from a cash-using institution to a self-sustaining concern with affirmative currency flow.

I'm pleased to study that successful 2025, we achieved that inflection point. During the year, we besides achieved respective different important milestones, continued gross growth, improved gross borderline and operational leverage, the workout of each remaining fiscal warrants, removing immoderate related overhang and the completion of the repayment of Change Healthcare loan, allowing the institution to determination towards a cleanable equilibrium sheet. For galore years, similar astir emerging diagnostic companies, we had to negociate the concern with a changeless constraint of conserving superior and extending our runway. That subject shaped our institution into the highly businesslike enactment that we are today, but it besides meant that galore decisions had to beryllium made with shorter superior preservation successful mind.

Today, we participate a caller signifier of the company's development. The subject remains, but we are present progressively capable to deploy resources towards maturation initiatives and semipermanent worth creation. The institution is moving from focusing chiefly connected stabilization to 1 progressively centered connected maturation and execution. And during the call, we'll item respective examples of that shift. Now fto maine crook to our fiscal results for the year. For fiscal twelvemonth 2025, Precipio delivered $24 cardinal successful revenue, representing a 30% summation year-over-year compared to 2024. This level of maturation reflects the continued enlargement chiefly successful our Pathology Services part arsenic good arsenic strengthening request for our specialized crab diagnostic services and molecular investigating technologies.